DHT.UN — DRI Healthcare Trust Share Price
0.000.00%
Last trade - 00:00- CA$638.57m
- CA$1.03bn
- CA$184.71m
- 29
- 65
- 67
- 53
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 3.88 | ||
| PEG Ratio (f) | 0.06 | ||
| EPS Growth (f) | 182.68% | ||
| Dividend Yield (f) | 4.59% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.21 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 4.11 | ||
| Price to Sales | 3.46 | ||
| EV to EBITDA | 7.81 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.27% | ||
| Return on Equity | -0.62% | ||
| Operating Margin | 15.97% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 79.86 | 87.27 | 158.91 | 184.71 | 248.71 | 256.76 | 32.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -53.26 | n/a | n/a | +1473.89 | +6.58 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 21st, 2020
- Public Since
- February 11th, 2021
- No. of Employees
- 36
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 56,310,920
- Address
- 1 First Canadian Place, Toronto, M5X 1B1
- Web
- https://drihealthcare.com/
- Phone
- +1 4168631865
- Auditors
- Deloitte LLP
Upcoming Events for DHT.UN
Q1 2025 Dri Healthcare Trust Earnings Release
Q1 2025 Dri Healthcare Trust Earnings Call
Q2 2025 Dri Healthcare Trust Earnings Release
Similar to DHT.UN
Aptose Biosciences
Toronto Stock Exchange
Aurora Cannabis
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
FAQ
What is the DRI Healthcare Trust share price?
As of Today at 20:19 UTC, shares in DRI Healthcare Trust are trading at CA$11.34. This share price information is delayed by 15 minutes.
How has the DRI Healthcare Trust share price performed this year?
Shares in DRI Healthcare Trust last closed at CA$11.34 and the price had moved by -31.44% over the past 365 days. In terms of relative price strength the DRI Healthcare Trust share price has underperformed the Toronto Stock Exchange 300 Composite Index by -39.04% over the past year.
What are the analyst and broker recommendations for DRI Healthcare Trust?
The overall consensus recommendation for DRI Healthcare Trust is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the DRI Healthcare Trust dividend yield?
The DRI Healthcare Trust dividend yield is 4.31% based on the trailing twelve month period.
Does DRI Healthcare Trust pay a dividend?
Last year, DRI Healthcare Trust paid a total dividend of CA$0.49, and it currently has a trailing dividend yield of 4.31%. We do not have any data on when DRI Healthcare Trust is to next pay dividends.
When does DRI Healthcare Trust next pay dividends?
We do not have data on when DRI Healthcare Trust is to next pay dividends. The historic dividend yield on DRI Healthcare Trust shares is currently 4.31%.
How do I buy DRI Healthcare Trust shares?
To buy shares in DRI Healthcare Trust you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DRI Healthcare Trust?
As of the previous close price of CA$11.34, shares in DRI Healthcare Trust had a market capitalisation of CA$638.57m.
Where are DRI Healthcare Trust shares listed?
Here are the trading details for DRI Healthcare Trust:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: DHT.UN
What kind of share is DRI Healthcare Trust?
Based on an overall assessment of its quality, value and momentum DRI Healthcare Trust is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DRI Healthcare Trust share price forecast for 2025?
The analyst consensus target price for shares in DRI Healthcare Trust is CA$20.03. That is 76.59% above the last closing price of CA$11.34.
Analysts covering DRI Healthcare Trust currently have a consensus Earnings Per Share (EPS) forecast of CA$2.86 for the next financial year.
Find out moreWhat is the trend in the DRI Healthcare Trust share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DRI Healthcare Trust. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -19.42%.
As of the last closing price of CA$11.34, shares in DRI Healthcare Trust were trading -7.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DRI Healthcare Trust PE Ratio?
The DRI Healthcare Trust PE ratio based on its reported earnings over the past 12 months is 3.88. The shares last closed at CA$11.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DRI Healthcare Trust?
We do not have data on DRI Healthcare Trust's directors